Carmell Co. (NASDAQ:CTCX – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 505,100 shares, an increase of 29.1% from the October 15th total of 391,200 shares. Based on an average daily volume of 4,600,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.8% of the shares of the company are short sold.
Institutional Investors Weigh In On Carmell
An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC bought a new stake in shares of Carmell Co. (NASDAQ:CTCX – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell as of its most recent SEC filing. 24.22% of the stock is owned by institutional investors and hedge funds.
Carmell Price Performance
Shares of NASDAQ CTCX traded down $0.06 during mid-day trading on Friday, reaching $0.22. 458,434 shares of the company traded hands, compared to its average volume of 1,414,628. Carmell has a fifty-two week low of $0.20 and a fifty-two week high of $4.31. The stock has a fifty day simple moving average of $0.38 and a 200-day simple moving average of $1.16.
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- What is a Low P/E Ratio and What Does it Tell Investors?
- Top-Performing Non-Leveraged ETFs This Year
- What Are Dividend Achievers? An Introduction
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What Makes a Stock a Good Dividend Stock?
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.
